Analyzing antigen recognition by natural killer T cells

Methods in Molecular Biology

Volumn 960, Issue , 2013, Pages 557-572

  Zeissig, Sebastian ^a,b   Olszak, Torsten ^a   Melum, Espen ^a   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

CD1d; Lipid antigen presentation; Natural Killer T cells; Tetramer; ' Galactosylceramide

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; INTERLEUKIN 12; TETRAMER; TOLL LIKE RECEPTOR; ANTIGEN; CD1 ANTIGEN; CD1B ANTIGEN; LIPID;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; ANIMAL; CELL LINE; CHEMISTRY; DIMERIZATION; IMMUNOLOGY; STAINING;

ANIMALS; ANTIGENS; ANTIGENS, CD1; CELL LINE; DIMERIZATION; HUMANS; LIPIDS; MICE; NATURAL KILLER T-CELLS; STAINING AND LABELING;

MLCS; MLOWN;

EID: 84879323390     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-218-6_41     Document Type: Article

References (32)

1. Cohen NR, Garg S, Brenner MB (2009) Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 102:1-94
2. Barral DC, Brenner MB (2007) CD1 antigen presentation: how it works. Nat Rev Immunol 7:929-941
3. de la Salle H et al (2005) Assistance of microbial glycolipid antigen processing by CD1e. Science 310:1321-1324
4. Park SH, Roark JH, Bendelac A (1998) Tissuespecific recognition of mouse CD1 molecules. J Immunol 160:3128-3134
5. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what's in a name' Nat Rev Immunol 4: 231-237
6. Zeissig S, Kaser A, Dougan SK, Nieuwenhuis EE, Blumberg RS (2007) Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am J Physiol Gastrointest Liver Physiol 293:G1101-G1105
7. Michel ML et al (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204:995-1001
8. Cardell S et al (1995) CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med 182:993-1004
9. Chiu YH et al (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189:103-110
10. Kasmar AG et al (2011) CD1b tetramers bind alpha}{beta T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 208(9):1741-1747
11. Odyniec AN et al (2010) Regulation of CD1 antigen-presenting complex stability. J Biol Chem 285:11937-11947
12. Dougan SK, Rava P, Hussain MM, Blumberg RS (2007) MTP regulated by an alternate promoter is essential for NKT cell development. J Exp Med 204:533-545
13. Dougan SK et al (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202:529-539
14. Kaser A et al (2008) Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur J Immunol 38:2351-2359
15. Zeissig S et al (2010) Primary de fi ciency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest 120:2889-2899
16. Tupin E, Kronenberg M (2006) Activation of natural killer T cells by glycolipids. Methods Enzymol 417:185-201
17. Koseki H et al (1990) Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice. Proc Natl Acad Sci U S A 87:5248-5252
18. Matsuda JL et al (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192:741-754
19. Halder RC, Aguilera C, Maricic I, Kumar V (2007) Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 117:2302-2312
20. Jahng A et al (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947-957
21. Montoya CJ et al (2007) Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122:1-14
22. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297-336
23. McNab FW et al (2005) The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol 175:3762-3768
24. Das R, Sant'Angelo DB, Sant'Angelo DB, Nichols KE (2010) Transcriptional control of invariant NKT cell development. Immunol Rev 238:195-215
25. Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat Rev Immunol 7:505-518
26. Lee PT et al (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 110:793-800
27. Kovalovsky D et al (2008) The BTB-zinc fi nger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 9:1055-1064
28. Savage AK et al (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29:391-403
29. Monteiro M et al (2010) Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 185:2157-2163
30. Yu KO et al (2007) Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d. J Immunol Methods 323:11-23
31. Roark JH et al (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 160:3121-3127
32. Dougan SK, Kaser A, Blumberg RS (2007) CD1 expression on antigen-presenting cells. Curr Top Microbiol Immunol 314:113-141